Uncovering the Molecular Secrets of Inflammatory Breast Cancer Biology: An Integrated Analysis of Three Distinct Affymetrix Gene Expression Datasets

Archive ouverte

van Laere, Steven | Ueno, Naoto | Finetti, Pascal | Vermeulen, Peter | Lucci, Anthony | Robertson, Fredika | Marsan, Melike | Iwamoto, Takayuki | Krishnamurthy, Savitri | Masuda, Hiroko | van Dam, Peter | Woodward, Wendy | Viens, Patrice | Cristofanilli, Massimo | Birnbaum, Daniel | Dirix, Luc | Reuben, James | Bertucci, François

Edité par CCSD ; American Association for Cancer Research -

International audience. Background: Inflammatory breast cancer (IBC) is a poorly characterized form of breast cancer. So far, the results of expression profiling in IBC are inconclusive due to various reasons including limited sample size. Here, we present the integration of three Affymetrix expression datasets collected through the World IBC Consortium allowing us to interrogate the molecular profile of IBC using the largest series of IBC samples ever reported.Experimental design: Affymetrix profiles (HGU133-series) from 137 patients with IBC and 252 patients with non-IBC (nIBC) were analyzed using unsupervised and supervised techniques. Samples were classified according to the molecular subtypes using the PAM50-algorithm. Regression models were used to delineate IBC-specific and molecular subtype-independent changes in gene expression, pathway, and transcription factor activation.Results: Four robust IBC-sample clusters were identified, associated with the different molecular subtypes (P<0.001), all of which were identified in IBC with a similar prevalence as in nIBC, except for the luminal A subtype (19% vs. 42%; P<0.001) and the HER2-enriched subtype (22% vs. 9%; P<0.001). Supervised analysis identified and validated an IBC-specific, molecular subtype-independent 79-gene signature, which held independent prognostic value in a series of 871 nIBCs. Functional analysis revealed attenuated TGF-β signaling in IBC.Conclusion: We show that IBC is transcriptionally heterogeneous and that all molecular subtypes described in nIBC are detectable in IBC, albeit with a different frequency. The molecular profile of IBC, bearing molecular traits of aggressive breast tumor biology, shows attenuation of TGF-β signaling, potentially explaining the metastatic potential of IBC tumor cells in an unexpected manner.

Consulter en ligne

Suggestions

Du même auteur

Genomic profiling of inflammatory breast cancer: A review

Archive ouverte | Bertucci, François | CCSD

International audience

Genomic landscape of inflammatory breast cancer identifies potential actionable genetic alterations

Archive ouverte | Bertucci, François | CCSD

International audience. No abstract available

Comparative transcriptional analyses of preclinical models and patient samples reveal MYC and RELA driven expression patterns that define the molecular landscape of IBC

Archive ouverte | Rypens, Charlotte | CCSD

International audience. Abstract Inflammatory breast cancer (IBC) is an aggressive disease for which the spectrum of preclinical models was rather limited in the past. More recently, novel cell lines and xenografts ...

Chargement des enrichissements...